Infinium Omni5Exome-4

Infinium Omni5Exome-4 (4-sample)
Overview

The Infinium Omni5Exome-4 v1.3 BeadChip delivers the most comprehensive genome-wide backbone in the Infinium Array Portfolio. This high-density array provides exceptional coverage of common, intermediate, and rare SNPs and leverages powerful tag SNPs selected from the International HapMap and 1000 Genomes Projects. The Infinium Omni5Exome-4 provides functional exonic content for whole-genome genotyping and copy number variation (CNV) analysis. Using the proven iScan System, integrated analysis software, and Infinium LCG Assay, this four-sample BeadChip provides optimized content for whole-genome genotyping, exonic content, and CNV applications.

The Infinium Omni5Exome-4 v1.3 kit is also compatible with the Illumina FFPE QC Kit and Infinium HD FFPE DNA Restore Kit. The Infinium Omni5Exome-4 v1.3 Kit includes convenient kit packaging containing reagents and BeadChips for amplifying, fragmenting, hybridizing, labeling and detecting DNA samples using the Infinium streamlined PCR-free protocol.

Order Now Support Training

Please rotate your device for details

Specifications
Product Information*
Total Number of Markers 4,559,465
Capacity for Custom Bead Types –
Number of samples per BeadChip 4
DNA Input 400 ng
Assay Chemistry Infinium LCG Quad
FFPE Compatible Yes
Spacing Mean Median 90th%
0.64 0.33 1.50

*Please see the Datasheet for additional product specifications.

LD Mean r2 for European, East Asian, and South Asian Populations from 1kGP at Different MAF Thresholds
Population 0.5–1% 1–5% ≥5%
AFR 0.18 0.42 0.74
AMR 0.58 0.70 0.90
EAS 0.25 0.55 0.91
EUR 0.57 0.81 0.93
SAS 0.34 0.61 0.91

Product and Ordering Information

  • HumanOmni5Exome v1.3 BeadChip Kits: 20005140 (16 samples), 20005141 (48 samples), 20005142 (96 samples), 20005143 (384 samples)

Support Links

Order Now Support Training
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.